BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36675288)

  • 1. ATP13A2 Gene Silencing in Drosophila Affects Autophagic Degradation of A53T Mutant α-Synuclein.
    Dhanushkodi NR; Abul Khair SB; Ardah MT; Haque ME
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of Glucocerebrosidase Gene in
    Abul Khair SB; Dhanushkodi NR; Ardah MT; Chen W; Yang Y; Haque ME
    Front Neurosci; 2018; 12():81. PubMed ID: 29503608
    [No Abstract]   [Full Text] [Related]  

  • 3. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential interaction between iron and mutant alpha-synuclein causes distinctive Parkinsonian phenotypes in Drosophila.
    Zhu ZJ; Wu KC; Yung WH; Qian ZM; Ke Y
    Biochim Biophys Acta; 2016 Apr; 1862(4):518-525. PubMed ID: 26769358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A
    Hu Q; Xu L; Liu X; Wang Y; Yuan J
    Neurosci Lett; 2024 Mar; 826():137610. PubMed ID: 38157926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation.
    Chen JY; Zhu Q; Cai CZ; Luo HB; Lu JH
    Phytomedicine; 2022 Jul; 101():154125. PubMed ID: 35525236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's Disease Associated α-Synuclein Familial Mutants Promote Dopaminergic Neuronal Death in Drosophila melanogaster.
    Mohite GM; Dwivedi S; Das S; Kumar R; Paluri S; Mehra S; Ruhela N; S A; Jha NN; Maji SK
    ACS Chem Neurosci; 2018 Nov; 9(11):2628-2638. PubMed ID: 29906099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
    Butler EK; Voigt A; Lutz AK; Toegel JP; Gerhardt E; Karsten P; Falkenburger B; Reinartz A; Winklhofer KF; Schulz JB
    PLoS Genet; 2012 Feb; 8(2):e1002488. PubMed ID: 22319455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).
    Daniel G; Musso A; Tsika E; Fiser A; Glauser L; Pletnikova O; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 Jan; 73():229-43. PubMed ID: 25461191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.
    Usenovic M; Knight AL; Ray A; Wong V; Brown KR; Caldwell GA; Caldwell KA; Stagljar I; Krainc D
    Hum Mol Genet; 2012 Sep; 21(17):3785-94. PubMed ID: 22645275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Parkinson's disease symptoms in α-synuclein transgenic monkeys.
    Niu Y; Guo X; Chen Y; Wang CE; Gao J; Yang W; Kang Y; Si W; Wang H; Yang SH; Li S; Ji W; Li XJ
    Hum Mol Genet; 2015 Apr; 24(8):2308-17. PubMed ID: 25552648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease.
    Sakai R; Suzuki M; Ueyama M; Takeuchi T; Minakawa EN; Hayakawa H; Baba K; Mochizuki H; Nagai Y
    PLoS One; 2019; 14(6):e0218261. PubMed ID: 31242217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo.
    Cresto N; Gardier C; Gaillard MC; Gubinelli F; Roost P; Molina D; Josephine C; Dufour N; Auregan G; Guillermier M; Bernier S; Jan C; Gipchtein P; Hantraye P; Chartier-Harlin MC; Bonvento G; Van Camp N; Taymans JM; Cambon K; Liot G; Bemelmans AP; Brouillet E
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits.
    Schultheis PJ; Fleming SM; Clippinger AK; Lewis J; Tsunemi T; Giasson B; Dickson DW; Mazzulli JR; Bardgett ME; Haik KL; Ekhator O; Chava AK; Howard J; Gannon M; Hoffman E; Chen Y; Prasad V; Linn SC; Tamargo RJ; Westbroek W; Sidransky E; Krainc D; Shull GE
    Hum Mol Genet; 2013 May; 22(10):2067-82. PubMed ID: 23393156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract.
    Shaltiel-Karyo R; Davidi D; Frenkel-Pinter M; Ovadia M; Segal D; Gazit E
    Biochim Biophys Acta; 2012 Oct; 1820(10):1628-35. PubMed ID: 22575665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Lysosomal Exocytosis Induced by Lysosomal Ca
    Tsunemi T; Perez-Rosello T; Ishiguro Y; Yoroisaka A; Jeon S; Hamada K; Rammonhan M; Wong YC; Xie Z; Akamatsu W; Mazzulli JR; Surmeier DJ; Hattori N; Krainc D
    J Neurosci; 2019 Jul; 39(29):5760-5772. PubMed ID: 31097622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.
    Rauschenberger L; Behnke J; Grotemeyer A; Knorr S; Volkmann J; Ip CW
    Neurobiol Dis; 2022 Sep; 171():105798. PubMed ID: 35750147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of mortalin/GRP75/mthsp70 in the mitochondrial impairments induced by A53T mutant α-synuclein.
    Liu FT; Chen Y; Yang YJ; Yang L; Yu M; Zhao J; Wu JJ; Huang F; Liu W; Ding ZT; Wang J
    Brain Res; 2015 Apr; 1604():52-61. PubMed ID: 25665531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The toxicities of A30P and A53T α-synuclein fibrils can be uniquely altered by the length and saturation of fatty acids in phosphatidylserine.
    Ali A; Zhaliazka K; Dou T; Holman AP; Kurouski D
    J Biol Chem; 2023 Dec; 299(12):105383. PubMed ID: 37890776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.